Clinical Trial Results:
International, randomized, open-label, Phase 3 trial of paclitaxel/carboplatin plus PF-3512676 versus paclitaxel/carboplatin alone as first-line treatment of patients with advanced non-small cell lung cancer
Summary
|
|
EudraCT number |
2005-004555-35 |
Trial protocol |
GB ES HU CZ DE SE BE PT GR IT |
Global completion date |
17 Jul 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
06 Mar 2016
|
First version publication date |
06 Mar 2016
|
Other versions |
|
Summary report(s) |
A8501001 EU Posting |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.